Medical Cannabis in Parkinson’s Disease

Clinical Neuropharmacology, 2023

A retrospective questionnaire-based survey that examined the effects of cannabis on the motor and non-motor symptoms of patients with Parkinson’s Disease. The mean age of the patients was 64.2 +/- 10.8 years, the mean disease duration was 10.8 +/- 8.3 years, and the duration of cannabis use was 19.1 +/- 17 months.

Key Results:

  • 82.2% of patients reported that cannabis improved their overall symptoms

  • 81.4% of patients reported that their pain was reduced

  • 76.1% of patients reported an improvement in mood

  • 73.2% of patients reported tremor reduction

  • 72.7% of patients reported reduced muscle stiffness

  • 71.1% of patients reported an improvement in sleep quality

Strains:

Various medical cannabis strains

Study Population:

47 patients with Parkinson’s Disease

View PDF